Login to Your Account



ADC's $105M private round year's largest by European biotech

By Nuala Moran
Staff Writer

Tuesday, October 18, 2016

LONDON – ADC Therapeutics Sarl has raised $105 million in the largest private funding round by any biotech in Europe this year, enabling the company to expand its pipeline of antibody-targeted chemotherapeutics to six programs.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription